Altimmune Inc (ALT)
5.74
-0.15
(-2.55%)
USD |
NASDAQ |
Mar 26, 10:12
Altimmune Max Drawdown (5Y): 99.74% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Viking Therapeutics Inc | 89.26% |
| Eli Lilly and Co | 24.27% |
| Amgen Inc | 24.86% |
| Terns Pharmaceuticals Inc | -- |
| Pfizer Inc | 54.78% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -2.541 |
| Beta (5Y) | 0.8692 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 180.4% |
| Historical Sharpe Ratio (5Y) | 0.0548 |
| Historical Sortino (5Y) | 0.2149 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.00% |